IMC Chicago’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.68M Sell
675,200
-52,800
-7% -$296K ﹤0.01% 2053
2025
Q4
$5.1M Sell
728,000
-332,300
-31% -$2.6M ﹤0.01% 1727
2025
Q3
$8.2M Buy
1,060,300
+212,000
+25% +$1.65M ﹤0.01% 1257
2025
Q2
$7.39M Buy
848,300
+294,800
+53% +$2.14M ﹤0.01% 1176
2025
Q1
$4.41M Buy
553,500
+250,200
+82% +$2.53M ﹤0.01% 1305
2024
Q4
$2.76M Sell
303,300
-44,700
-13% -$432K ﹤0.01% 1629
2024
Q3
$3.19M Buy
348,000
+19,900
+6% +$165K ﹤0.01% 1378
2024
Q2
$3.21M Buy
328,100
+119,600
+57% +$1.46M ﹤0.01% 1296
2024
Q1
$3.15M Buy
208,500
+1,400
+0.7% +$25.4K ﹤0.01% 1150
2023
Q4
$4.46M Sell
207,100
-48,600
-19% -$897K ﹤0.01% 922
2023
Q3
$4.75M Buy
255,700
+32,800
+15% +$766K ﹤0.01% 749
2023
Q2
$5.64M Sell
222,900
-99,600
-31% -$2.51M 0.01% 648
2023
Q1
$8.35M Buy
322,500
+91,000
+39% +$2.44M 0.01% 535
2022
Q4
$5.47M Sell
231,500
-41,000
-15% -$1.11M 0.01% 587
2022
Q3
$6.91M Sell
272,500
-244,400
-47% -$8.57M 0.01% 504
2022
Q2
$17.2M Sell
516,900
-63,700
-11% -$2.71M 0.02% 318
2022
Q1
$41.9M Sell
580,600
-78,300
-12% -$5.64M 0.04% 194
2021
Q4
$60.5M Buy
658,900
+298,800
+83% +$35.7M 0.05% 169
2021
Q3
$45.7M Sell
360,100
-135,400
-27% -$19.7M 0.05% 193
2021
Q2
$82.4M Buy
495,500
+91,600
+23% +$14.8M 0.1% 110
2021
Q1
$73.4M Buy
403,900
+183,100
+83% +$42.5M 0.11% 95
2020
Q4
$44.2M Buy
220,800
+72,100
+48% +$14.7M 0.06% 142
2020
Q3
$32.6M Buy
148,700
+68,100
+84% +$14.4M 0.05% 124
2020
Q2
$15.4M Buy
80,600
+67,100
+497% +$11.8M 0.03% 201
2020
Q1
$2.09M Buy
+13,500
New +$1.57M ﹤0.01% 489

Other funds holding TDOC

IMC Chicago's TDOC Position: Q1 2026 in Review

IMC Chicago sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 235,521 shares — an estimated $1.32M sold.

IMC Chicago first reported a position in TDOC in Q1 2021 and held it in 14 quarters. The position peaked at $5.21M in Q2 2025. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • IMC Chicago reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 235,521 Teladoc Health shares in Q1 2026, an estimated $1.32M.
  • IMC Chicago first reported a position in Teladoc Health in Q1 2021 and held it in 14 quarters.
  • IMC Chicago's Teladoc Health position peaked at $5.21M in Q2 2025.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.